Traditional uses
|
Respiratory tract |
Cough, Asthma |
Powder syrup |
In vivo |
Ardabil, Iran |
Eskandarpour et al. (2024) |
Pneumonia and Atelectasis |
Essential oil |
In vivo |
Sari, Iran |
Ghahremani Chabok et al. (2021) |
SARS‐CoV‐2 |
Essential oil |
In vivo |
Zanjan, Iran |
Sardari et al. (2021) |
COVID‐19 |
Leaves dry powder |
In vivo |
Cameroon |
Yiagnigni Mfopou et al. (2021) |
Acute pneumonitis |
Aerial parts |
In vivo |
Pécs, Hungary |
Csikós et al. (2020) |
Acute bronchitis |
Dry extracts |
In vitro/In vivo |
Germany |
Seibel et al. (2018) |
Nervous system |
Analgesic activity/motor impairment |
Aerial parts/thyme tincture and syrup |
In vivo |
Serbia |
Rašković et al. (2021) |
Alzheimer's disease |
Essential oil |
In vivo |
Romania |
Capatina et al. (2020) |
Encephalomyelitis/Multiple sclerosis (MS) |
Aerial parts |
In vivo |
Iran |
Mahmoodi et al. (2019) |
Cardiovascular system |
Hyperlipidemia |
Leaves dry powder |
In vivo |
India |
Ghai and Saraswat (2023) |
Coronary angiogenesis |
Not defined |
In vivo |
— |
Roshankhah et al. (2020) |
Hyperlipidemia |
Leaves dry powder |
In vivo |
Iran |
KoohiHosseinabadi et al. (2015) |
Anxiety |
Dry extracts |
In vivo |
Iran |
Shaban et al. (2015) |
Digestive system |
Gastrointestinal disorders |
Leaves dry powder |
In vivo |
Tunisia |
Rtibi et al. (2019) |
Ulcer and ulcerative colitis |
Essential oil |
In vivo |
Egypt |
Hamed et al. (2022) |
Intestinal diseases |
Essential oil |
In vivo |
Peru |
Rojas Armas et al. (2019) |
Others |
Diuretic properties |
Aerial parts |
In vitro/In vivo |
Romania |
Babotă et al. (2023) |
Emphysema |
Essential oil |
In vivo |
Sari, Iran |
Ghahremani Chabok et al. (2021) |
COPD |
Dry extracts |
In vitro |
Italy |
Nabissi et al. (2018) |